Influence of daily setup measurements and corrections on the estimated delivered dose during IMRT treatment of prostate cancer patients

Radiotherapy and Oncology

Volumn 90, Issue 3, 2009, Pages 291-298

  van Haaren, Paul M A ^a   Bel, Arjan ^a   Hofman, Pieter ^b   van Vulpen, Marco ^b   Kotte, Alexis N T J ^b   van der Heide, Uulke A ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Estimated delivered dose; Fiducial markers; IMRT; Prostate cancer; Setup corrections

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DOSIMETRY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE;

HUMANS; MALE; ORGAN SIZE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; URINARY BLADDER;

EID: 61349134730     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.12.021     Document Type: Article

References (45)

1. Astreinidou E., Bel A., Raaijmakers C.P., Terhaard C.H., and Lagendijk J.J. Adequate margins for random setup uncertainties in head-and-neck IMRT. Int J Radiat Oncol Biol Phys 61 (2005) 938-944
2. Balter J.M., Sandler H.M., Lam K., Bree R.L., Lichter A.S., and Ten Haken R.K. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys 31 (1995) 113-118
3. Beckham W.A., Keall P.J., and Siebers J.V. A fluence-convolution method to calculate radiation therapy dose distributions that incorporate random set-up error. Phys Med Biol 47 (2002) 3465-3473
4. Bel A., Vos P.H., Rodrigus P.T., Creutzberg C.L., Visser A.G., Stroom J.C., et al. High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys 35 (1996) 321-332
5. Beltran C., Herman M.G., and Davis B.J. Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods. Int J Radiat Oncol Biol Phys 70 (2008) 289-295
6. Boehmer D., Kuczer D., Badakhshi H., Stiefel S., Kuschke W., Wernecke K.D., et al. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy. Strahlenther Onkol 182 (2006) 277-282
7. Bortfeld T., Jiang S.B., and Rietzel E. Effects of motion on the total dose distribution. Semin Radiat Oncol 14 (2004) 41-51
8. Bos L.J., Damen E.M., De Boer R.W., Mijnheer B.J., McShan D.L., Fraass B.A., et al. Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. Int J Radiat Oncol Biol Phys 52 (2002) 254-265
9. Bos L.J., Van der Geer J., Van Herk M., Mijnheer B.J., Lebesque J.V., and Damen E.M. The sensitivity of dose distributions for organ motion and set-up uncertainties in prostate IMRT. Radiother Oncol 76 (2005) 18-26
10. Chen M.E., Johnston D.A., Tang K., Babaian R.J., and Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89 (2000) 1800-1809
11. Cho P.S., Johnson R.H., and Griffin T.W. Cone-beam CT for radiotherapy applications. Phys Med Biol 40 (1995) 1863-1883
12. Craig T., Battista J., and Van Dyk J. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy II. The effect of a finite number of fractions. Med Phys 30 (2003) 2012-2020
13. Craig T., Battista J., and Van Dyk J. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy I. The effect of shift invariance. Med Phys 30 (2003) 2001-2011
14. De Boer J.C., and Heijmen B.J. A new approach to off-line setup corrections: combining safety with minimum workload. Med Phys 29 (2002) 1998-2012
15. De Crevoisier R., Tucker S.L., Dong L., Mohan R., Cheung R., Cox J.D., et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 965-973
16. De Neve W., De Gersem W., Fortan L., and Van den Heuvel F. Clinical implementation of electronic portal imaging: correction strategies and set-up errors. Bull Cancer Radiother 83 (1996) 401-405
17. Dehnad H., Nederveen A.J., Van der Heide U.A., Van Moorselaar R.J., Hofman P., and Lagendijk J.J. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 67 (2003) 295-302
18. Deurloo K.E., Steenbakkers R.J., Zijp L.J., de Bois J.A., Nowak P.J., Rasch C.R., et al. Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 228-238
19. Fiorino C., Fellin G., Rancati T., Vavassori V., Bianchi C., Borca V.C., et al. Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a multicenter prospective study. Int J Radiat Oncol Biol Phys 70 (2008) 1130-1137
20. Ford E.C., Chang J., Mueller K., Sidhu K., Todor D., Mageras G., et al. Cone-beam CT with megavoltage beams and an amorphous silicon electronic portal imaging device: potential for verification of radiotherapy of lung cancer. Med Phys 29 (2002) 2913-2924
21. Goitein M., and Niemierko A. Intensity modulated therapy and inhomogeneous dose to the tumor: a note of caution. Int J Radiat Oncol Biol Phys 36 (1996) 519-522
22. Hoogeman M.S., Van Herk M., Yan D., Boersma L.J., Koper P.C., and Lebesque J.V. A model to simulate day-to-day variations in rectum shape. Int J Radiat Oncol Biol Phys 54 (2002) 615-625
23. Jackson A., Skwarchuk M.W., Zelefsky M.J., Cowen D.M., Venkatraman E.S., Levegrun S., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer II. Volume effects and dose-volume histograms. Int J Radiat Oncol Biol Phys 49 (2001) 685-698
24. Kestin L.L., Goldstein N.S., Vicini F.A., Yan D., Korman H.J., and Martinez A.A. Treatment of prostate cancer with radiotherapy: should the entire seminal vesicles be included in the clinical target volume?. Int J Radiat Oncol Biol Phys 54 (2002) 686-697
25. Litzenberg D., Dawson L.A., Sandler H., Sanda M.G., McShan D.L., Ten Haken R.K., et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys 52 (2002) 699-703
26. Nederveen A., Lagendijk J., and Hofman P. Detection of fiducial gold markers for automatic on-line megavoltage position verification using a marker extraction kernel (MEK). Int J Radiat Oncol Biol Phys 47 (2000) 1435-1442
27. Nederveen A.J., Dehnad H., Van der Heide U.A., Van Moorselaar R.J., Hofman P., and Lagendijk J.J. Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. Radiother Oncol 68 (2003) 81-88
28. Nederveen A.J., Lagendijk J.J., and Hofman P. Feasibility of automatic marker detection with an a-Si flat-panel imager. Phys Med Biol 46 (2001) 1219-1230
29. Nederveen A.J., Van der Heide U.A., Hofman P., Welleweerd H., and Lagendijk J.J. Partial boosting of prostate tumours. Radiother Oncol 61 (2001) 117-126
30. Peeters S.T., Heemsbergen W.D., Koper P.C., Van Putten W.L., Slot A., Dielwart M.F., et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 24 (2006) 1990-1996
31. Pisansky T.M., Blute M.L., Suman V.J., Bostwick D.G., Earle J.D., and Zincke H. Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. Int J Radiat Oncol Biol Phys 36 (1996) 585-591
32. Pollack A., Zagars G.K., Starkschall G., Antolak J.A., Lee J.J., Huang E., et al. Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53 (2002) 1097-1105
33. Ruchala K.J., Olivera G.H., Kapatoes J.M., Schloesser E.A., Reckwerdt P.J., and Mackie T.R. Megavoltage CT image reconstruction during tomotherapy treatments. Phys Med Biol 45 (2000) 3545-3562
34. Song W.Y., Schaly B., Bauman G., Battista J.J., and Van Dyk J. Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: a radiobiologic analysis. Int J Radiat Oncol Biol Phys 64 (2006) 289-300
35. Song W.Y., Wong E., Bauman G.S., Battista J.J., and Van Dyk J. Dosimetric evaluation of daily rigid and nonrigid geometric correction strategies during on-line image-guided radiation therapy (IGRT) of prostate cancer. Med Phys 34 (2007) 352-365
36. Stroom J.C., De Boer H.C., Huizenga H., and Visser A.G. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. Int J Radiat Oncol Biol Phys 43 (1999) 905-919
37. Stroom J.C., and Heijmen B.J. Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 report. Radiother Oncol 64 (2002) 75-83
38. Thames H.D., Schultheiss T.E., Hendry J.H., Tucker S.L., Dubray B.M., and Brock W.A. Can modest escalations of dose be detected as increased tumor control?. Int J Radiat Oncol Biol Phys 22 (1992) 241-246
39. Van der Heide U.A., Kotte A.N., Dehnad H., Hofman P., Lagenijk J.J., and Van Vulpen M. Analysis of fiducial marker-based position verification in the external beam radiotherapy of patients with prostate cancer. Radiother Oncol 82 (2007) 38-45
40. Van Herk M. Errors and margins in radiotherapy. Semin Radiat Oncol 14 (2004) 52-64
41. Van Herk M., Bruce A., Kroes A.P., Shouman T., Touw A., and Lebesque J.V. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys 33 (1995) 1311-1320
42. Van Herk M., Remeijer P., Rasch C., and Lebesque J.V. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 1121-1135
43. Webb S., and Nahum A.E. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 38 (1993) 653-666
44. Wu J., Haycocks T., Alasti H., Ottewell G., Middlemiss N., Abdolell M., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 61 (2001) 127-133
45. Zietman A.L., DeSilvio M.L., Slater J.D., Rossi Jr. C.J., Miller D.W., Adams J.A., et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294 (2005) 1233-1239